These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 26752337)

  • 1. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
    Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
    PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
    Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
    BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
    Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
    Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
    Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
    QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones.
    Simonov M; Abel EA; Skanderson M; Masoud A; Hauser RG; Brandt CA; Wilson FP; Laine L
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):72-79.e21. PubMed ID: 32147588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.
    Cholin L; Ashour T; Mehdi A; Taliercio JJ; Daou R; Arrigain S; Schold JD; Thomas G; Nally J; Nakhoul NL; Nakhoul GN
    BMC Nephrol; 2021 Jul; 22(1):264. PubMed ID: 34266395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
    Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor Use, H
    Paik JM; Rosen HN; Gordon CM; Curhan GC
    Calcif Tissue Int; 2018 Oct; 103(4):380-387. PubMed ID: 29754277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
    Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
    BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.